1Van Duijn CM,Van Broeckhoven C,Hardy JA,et al.Evidence for allelic heterogeneity in familial early onset Alzheimer's disease[J].British J psychiatry,1991,158:471-474.
2Wisniewski T,Palha JA,Ghiso J,et al.S182 protein in Alzheimer's disease neuritic plaque[J].Lancet,1995,3:346-366.
3Mintzer J E.Introduction:the clinical impact of agitation in various psychiatric disorders:management consensus and controversies[J].Clinical Psychiatry,2006,67:324-336.
4Holmes C.Genotype and phenotype in Alzheimer's disease[J].British Journal of.Psychiatry,2002,180:131-134.
5Perez-Tur J,Froelich S,Prihar G,et al.A mutation in Alzheimer's disease destroying a splice accepter site in the presenilin-1 gene[J].Neuro Report,1995,7:297 -301.
6Liddell MB,Lovestone S.Genetic risk of Alzheimer's disease:advising relatives[J].British Journal of Psychiatry,2001,178:7-11.
7Norton LE,Malloy PF,Salloway S,et al.The impact of behavioral symptoms on activities of daily living in patients with dementia[J].Geriatr Psychiatry,2001,9:41-48.
3Li X,Westman E,St hlbom AK,et al. White matter changes in fami|ia[ Alzheimer's disease[J].J Intern Med, 2015,278 (2) : 211-218.
4Coon K, Myers AD,Webster J,et al. A high-density whole-ge home association study reveals that APOE is the maior suscep- tibility gene for sporadic late-onset Alzheimer's disease[J]. J Clin Psychiatry,2007,68(4) :613-618.
5Waring SC,Rosenberg RN. Genome-wide association studies in Alzheimer disease[J]. Arch Neurol, 2008,65 (3) : 329-334.
6De Jonghe CD, Esselens C, Kumar-Singh S, et al. Pathogenic APP mutations near the gamma-seeretase cleavage site differ entially affect Abeta secretion and APP C terminal fragment stability[J].Hum Mol Genet,2001,10(16) :1 665-1 671.
7Prasher VP, Farrer MJ, Kessling AM, et al. Molecular mapping of Alzheimer-type dementia in Down's syndrome[J]. Ann Neu- ro1,1998,43(3) : 380-383.
8Campion D, Dumanchin C, H annequin D, et al. Early-onset au- tosomal dominant Alzheimer disease: prevalence,genetic het- erogeneity,and mutation spectrum[J]. Am J Hum Genet, 1999,65(3) :664-670.
9Wolfe MS,Xia W,Ostaszewski BL,et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteoly sis and gamma-secretase activity[J]. Nature, 1999, 398 (6 727) :513-517.
10Marc C, Jessie T, Christine VB. Locus-Specific Mutation Da- tabases for Neurodegenerative Brain Diseases[J]. Hum Mu tat,2012,33(9) :1 340-1 344.
